Literature DB >> 25147262

Idiosyncratic liver injury induced by vildagliptin with successful switch to linagliptin in a hemodialyzed diabetic patient.

Noriaki Kurita1, Takako Ito2, Sayaka Shimizu3, Takumi Hirata4, Hirotsugu Uchihara5.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25147262     DOI： 10.2337/dc14-1252

Source DB:  PubMed          Journal:  Diabetes Care        ISSN： 0149-5992            Impact factor:   19.112


× No keyword cloud information.
  3 in total

1.  Acute Liver Injury Induced by Sitagliptin: Report of Two Cases and Review of Literature.

Authors:  Amir Shahbaz; Kashif Aziz; Muhammad Umair; Mohaddeseh Sharifzadeh; Issac Sachmechi
Journal:  Cureus       Date:  2018-06-11

2.  CMD-05, a novel promising clinical anti-diabetic drug candidate, in vivo and vitro studies.

Authors:  Jie Ma; Huan Li; Xiangnan Hu; Lu Yang; Qi Chen; Congli Hu; Zhihao Chen; Xiaoyan Tian; Yang Yang; Ying Luo; Run Gan; Junqing Yang
Journal:  Sci Rep       Date:  2017-04-13       Impact factor: 4.379

3.  Vildagliptin and its metabolite M20.7 induce the expression of S100A8 and S100A9 in human hepatoma HepG2 and leukemia HL-60 cells.

Authors:  Mitsutoshi Asakura; Fumika Karaki; Hideaki Fujii; Koichiro Atsuda; Tomoo Itoh; Ryoichi Fujiwara
Journal:  Sci Rep       Date:  2016-10-19       Impact factor: 4.379
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.